NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects Treatment Outcome Remove constraint Subjects: Treatment Outcome

Search Results

1. Are you ready to respond?: reports of high harm complications after surgery and invasive procedures

4. Dupilumab and crisaborole for atopic dermatitis: effectiveness and value : final evidence report and meeting summary

5. Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer: effectiveness and value : final evidence report

6. Cognitive and mind-body therapies for chronic low back and neck pain: effectiveness and value : final evidence report

9. Health care without the doctor: how new devices and technologies aid clinicians and consumers

21. Mémoire à consulter pour M. Jules Guérin, contre MM. Malgaigne, Vidal (de Cassis) et Henroz

24. The comparative clinical effectiveness and value of simeprevir and sofosbuvir in the treatment of chronic hepatitis C infection: a technology assessment : final report

25. Management of patients with opioid dependence: a review of clinical, delivery system, and policy options

26. Controversies in the management of patients with type 2 diabetes: final report

27. PCSK9 inhibitors for treatment of high cholesterol: effectiveness, value, and value-based price benchmarks : final report

28. Obeticholic acid for the treatment of primary biliary cholangitis: comparative clinical effectiveness, value, and value-based price benchmarks : evidence report

29. Disease-modifying therapies for relapsing-remitting and primary-progressive multiple sclerosis: effectiveness and value : final evidence report

30. Targeted immune modulators for rheumatoid arthritis: effectiveness & value : evidence report

31. Controversies in migraine management: a technology assessment : final report

38. Indications for and management of inferior vena cava filters

39. Timely treatment of stroke symptoms in the emergency department may improve outcomes

40. Sterile water should not be given "freely"

42. Fracture tables

45. Voretigene neparvovec for biallelic RPE65-mediated retinal disease: effectiveness and value : final evidence report

46. Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report

47. Emicizumab for hemophilia A with inhibitors: effectiveness and value : final evidence report

48. Modulator treatments for cystic fibrosis: effectiveness and value : final evidence report and meeting summary

49. Calcitonin gene-related peptide (CGRP) inhibitors as preventive treatments for patients with episodic or chronic migraine: effectiveness and value : final evidence report

50. Elagolix for treating endometriosis: final evidence report

51. Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: effectiveness and value : condition update : final evidence report

52. Inotersen and patisiran for hereditary transthyretin amyloidosis: effectiveness and value : final evidence report

53. Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer: effectiveness and value : final evidence report

54. Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors: effectiveness and value : final evidence report

55. Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report

56. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report

82. Belimumab and voclosporin for lupus nephritis: effectiveness and value : final report

83. Treatments for anemia in chronic kidney disease: effectiveness and value : final evidence report

84. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: Effectiveness and value : final report

85. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value : final evidence report